Promomed launches a new drug Velgia for the treatment of overweight and obesity of any severity. Registration procedure for the drug, produced on a full cycle from substance to finished dosage form, has been completed. First batches will go on sale in Q4 2024.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept